403 results in Exploration of Targeted Anti-tumor Therapy
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Original Article
Clinical and mutational profile of AT-rich interaction domain 1A-mutated cancers
Rosa Falcone ... Gennaro Daniele
Published: August 31, 2023 Explor Target Antitumor Ther. 2023;4:716–726
Open Access
Review
Protein ISGylation: a posttranslational modification with implications for malignant neoplasms
Angeles C. Tecalco-Cruz, Jesús Zepeda-Cervantes
Published: August 31, 2023 Explor Target Antitumor Ther. 2023;4:699–715
This article belongs to the special issue Posttranslational Modifications in Health and Disease
Open Access
Review
Anticancer action of naturally occurring emodin for the controlling of cervical cancer
Priyanka S. Lande ... Leena P. Joge
Published: August 31, 2023 Explor Target Antitumor Ther. 2023;4:690–698
This article belongs to the special issue Plant Extracts as an Infinite Resource for New Anticancer Agents
Open Access
Perspective
Artificial intelligence ethics in precision oncology: balancing advancements in technology with patient privacy and autonomy
Bahareh Farasati Far
Published: August 31, 2023 Explor Target Antitumor Ther. 2023;4:685–689
This article belongs to the special issue Artificial Intelligence for Precision Oncology
Open Access
Original Article
Deep learning based clinico-radiological model for paediatric brain tumor detection and subtype prediction
Abhishek Mahajan ... Aliasgar Moiyadi
Published: August 30, 2023 Explor Target Antitumor Ther. 2023;4:669–684
This article belongs to the special issue Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment
Open Access
Original Article
Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer
Abhishek Mahajan ... Kumar Prabhash
Published: August 30, 2023 Explor Target Antitumor Ther. 2023;4:657–668
This article belongs to the special issue Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment
Open Access
Review
Nanomedicine strategies to counteract cancer stemness and chemoresistance
Huayu Liu ... Ran Mo
Published: August 30, 2023 Explor Target Antitumor Ther. 2023;4:630–656
Open Access
Review
Nuclear epidermal growth factor receptor as a therapeutic target
Benjamin Atwell ... Joyce Schroeder
Published: August 30, 2023 Explor Target Antitumor Ther. 2023;4:616–629
This article belongs to the special issue Innovative Strategies to Target Triple-negative Breast Cancer
Open Access
Review
Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer
Ashley J. Hoskin ... Emma E. Vincent
Published: August 28, 2023 Explor Target Antitumor Ther. 2023;4:600–615
Open Access
Review
B-cell lymphoma 2 family members and sarcomas: a promising target in a heterogeneous disease
Rui Caetano Oliveira ... José Casanova
Published: August 24, 2023 Explor Target Antitumor Ther. 2023;4:583–599
This article belongs to the special issue The Role of Bcl-2 Family Proteins in Cancer Progression and Their Relevance to Cancer Therapy
Open Access
Review
Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology
Ashish Kumar Jha ... Andre Dekker
Published: August 24, 2023 Explor Target Antitumor Ther. 2023;4:569–582
This article belongs to the special issue Artificial Intelligence for Precision Oncology
Open Access
Perspective
Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma
Sayuri Yoshikawa ... Satoru Matsuda
Published: August 24, 2023 Explor Target Antitumor Ther. 2023;4:556–568
This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment
Open Access
Review
Current role of machine learning and radiogenomics in precision neuro-oncology
Teresa Perillo ... Andrea Manto
Published: July 19, 2023 Explor Target Antitumor Ther. 2023;4:545–555
This article belongs to the special issue Artificial Intelligence for Precision Oncology
Open Access
Review
An introductory review of post-resection chemotherapeutics for primary brain tumors
Meaghan McGovern ... Brandon Lucke-Wold
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:537–544
Open Access
Review
Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
Qiuyue Zhang ... Mengsen Li
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:519–536
This article belongs to the special issue Therapeutic Targeting of the Tumor Microenvironment
Open Access
Case Report
Spontaneous regression of a metastatic carcinoma transmitted by a kidney graft
Mikhail V. Kiselevskiy ... Irina Zh. Shubina
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:511–518
Open Access
Review
Increasing differential diagnosis between lipoma and liposarcoma through radiomics: a narrative review
Raffaele Natella ... Antonella Santone
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:498–510
This article belongs to the special issue Artificial Intelligence for Precision Oncology
Open Access
Review
Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential
Eric Jou
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:474–497
This article belongs to the special issue Therapeutic Targeting of the Tumor Microenvironment
Open Access
Perspective
Potential tactics with vitamin D and certain phytochemicals for enhancing the effectiveness of immune-checkpoint blockade therapies
Ai Tsuji ... Satoru Matsuda
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:460–473
This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment
Open Access
Original Article
Continuous enzyme activity assay for high-throughput classification of histone deacetylase 8 inhibitors
Markus Schweipert ... Franz-Josef Meyer-Almes
Published: June 30, 2023 Explor Target Antitumor Ther. 2023;4:447–459
Previous